Valiant Laboratories Limited (NSE:VALIANTLAB)
India
· Delayed Price · Currency is INR 81.65
+2.03 (2.55%)
Apr 29, 2026, 3:29 PM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 4.32 billion as of April 29, 2026. Its market cap has increased by 11.73% in one year.
Market Cap
4.32B
Enterprise Value
4.23B
Revenue
2.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
81.65
Market Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 4.32B, a decrease of -41.54%. That is a compound annual growth rate of -18.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 4.32B | 13.74% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bafna Pharmaceuticals | 3.16B |
| Nectar Lifesciences | 2.44B |
| Sigachi Industries | 8.04B |
| Brooks Laboratories | 1.90B |
| Ind-Swift Laboratories | 11.65B |
| Alpa Laboratories | 1.44B |
| Beta Drugs | 13.25B |
| Jagsonpal Pharmaceuticals | 13.67B |